{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2004"],"condition":["Colon Cancer","Colorectal Neoplasms","Rectal Cancer"],"disease":["Colon Cancer","Colorectal Neoplasms","Rectal Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2012151"],"study_start_month":["12"],"keyword":["Motesanib diphosphate","Panitumumab","AMG 706"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer","description":"The purpose of this study is to characterize the safety and tolerability of AMG 706 plus panitumumab when administered with either FOLFIRI or FOLFOX4 chemotherapy regimens. This is a Phase 1b clinical study.","dates":{"creation":"2004-12-15"},"accession":"2012151","cross_references":{"ClinicalTrials___gov":["NCT00101894"]}}